Posters & Presentations

RYZ101-225Ac-DOTATATE--carboplatin--etoposide--atezolizumab-in-somatostatin-receptor-expressing-extensive-stage-SCLC-thumb
RYZ101-225Ac-DOTATATE-pembrolizumab-in-estrogen-receptor-thumb
68Ga-Ga-RAYZ-8009--A-Glypican-3–Targeted-Diagnostic-Radiopharmaceutical-for-Hepatocellular-Carcinoma-Molecular-Imaging—A-First-in-Human-Case-Series-thumb
RayzeBio-WCLC-2024-Presentation-thumb
RYZ101-301 ASCO 2024 ACTION-1 ORAL for SNMMI 03-Jun-2024 thumb
Phase-1b-portion-of-the-ACTION-1-phase-1b-3-trial-of-RYZ101-in-gastroenteropancreatic-neuroendocrine-tumors-progressing-after-177Lu-somatostatin-analog-therapy--Safety-and-efficacy-findings-thumb
225Ac--DOTATATE-(RYZ101)-dosimetry-results-from-Part-1-of-the-ACTION-1-Trial-thumb
225ac-dotatae publication thumbnail
neuroendocrine-tumors-progressing-after-177Lu-somatostatin-analogue-therapy--initial-safety-analysis-thumb
GPC3-targeted-thumb